Chronic inflammation has been implicated in the development of various cancers. Inflammatory cells can produce reactive oxygen species and cytokines that damage DNA and promote mutations. Additionally, the inflammatory environment can support cancer cell survival, proliferation, and metastasis. Conditions such as chronic inflammatory bowel disease are well-documented risk factors for colorectal cancer. Addressing chronic inflammation might, therefore, reduce cancer risk and improve outcomes.
